Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Non-Current Deferred Tax Liability (2022 - 2023)

Adial Pharmaceuticals' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $22897.0 for Q1 2023.

  • For Q1 2023, Non-Current Deferred Tax Liability fell 2.15% year-over-year to $22897.0; the TTM value through Mar 2023 reached $22897.0, down 2.15%, while the annual FY2022 figure was $1690.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2023 was $22897.0 at Adial Pharmaceuticals, up from $1690.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $23399.0 in Q1 2022 and bottomed at $1690.0 in Q4 2022.